Tolerance and rebound with zafirlukast in patients with persistent asthma

BACKGROUND: The potential for tolerance to develop to zafirlukast, a cysteinyl leukotriene (CysLT) receptor antagonist (LRA) in persistent asthma, has not been specifically examined. OBJECTIVE: To look for any evidence of tolerance and potential for short-term clinical worsening on LRA withdrawal. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Reid, David W, Misso, Neil L, Aggarwal, Shashi, Thompson, Philip J, Johns, David P, Walters, E Haydn
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426667/
https://www.ncbi.nlm.nih.gov/pubmed/18489783
http://dx.doi.org/10.1186/1477-5751-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426667/
https://www.ncbi.nlm.nih.gov/pubmed/18489783
http://dx.doi.org/10.1186/1477-5751-7-3

Ejemplares similares